Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports

A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection...

Full description

Main Authors: Isaac, Cassiano Rodrigues, Chalita, Maria Regina Catai, Pinto, Luciana D.
Format: Artigo
Language: English
Published: Conselho Brasileiro de Oftalmologia 2017
Subjects:
Online Access: http://repositorio.unb.br/handle/10482/28266
Tags: Add Tag
No Tags, Be the first to tag this record!
id ir-10482-28266
recordtype dspace
spelling ir-10482-282662019-03-28T14:02:45Z Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports Botox® após Botox® - uma nova abordagem para tratamento de diplopia secundária ao uso cosmético de toxina botulínica: relatos de casos Isaac, Cassiano Rodrigues Chalita, Maria Regina Catai Pinto, Luciana D. Botulinum toxins, type A Strabismus Diplopia Neuromuscular agents Humans Female Adult Case reports Toxinas botulínicas tipo A Estrabismo Diplopia Fármacos neuromusculares Humanos Feminino Adulto Relatos de casos A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting. Uma nova técnica para tratamento de diplopia secundária ao uso estético da toxina botulínica A é descrito. Nestes relatos de casos, dois pacientes consecutivos que desenvolveram diplopia após uso cosmético de toxina botulínica A periocular foram tratados com injeção de toxina botulínica A no músculo extraocular antagonista. A diplopia melhorou em menos de uma semana nos dois pacientes, sem efeitos colaterais. Consideramos o uso de injeção intramuscular de toxina botulínica A como uma possível opção para o tratamento da diplopia secundária ao uso da toxina botulínica A para rejuvenescimento facial. 2017-12-07T04:58:04Z 2017-12-07T04:58:04Z 2012 Artigo Arq. Bras. Oftalmol.,v.75,n.3,p.213-214,2012 0004-2749 http://repositorio.unb.br/handle/10482/28266 10.1590/S0004-27492012000300014 en Acesso Aberto application/pdf Conselho Brasileiro de Oftalmologia http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492012000300014&lng=en&nrm=iso http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0004-27492012000300014&lng=en&nrm=iso http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0004-27492012000300014&lng=en&nrm=iso
institution REPOSITORIO UNB
collection REPOSITORIO UNB
language English
topic Botulinum toxins, type A
Strabismus
Diplopia
Neuromuscular agents
Humans
Female
Adult
Case reports
Toxinas botulínicas tipo A
Estrabismo
Diplopia
Fármacos neuromusculares
Humanos
Feminino
Adulto
Relatos de casos
spellingShingle Botulinum toxins, type A
Strabismus
Diplopia
Neuromuscular agents
Humans
Female
Adult
Case reports
Toxinas botulínicas tipo A
Estrabismo
Diplopia
Fármacos neuromusculares
Humanos
Feminino
Adulto
Relatos de casos
Isaac, Cassiano Rodrigues
Chalita, Maria Regina Catai
Pinto, Luciana D.
Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
description A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting.
format Artigo
author Isaac, Cassiano Rodrigues
Chalita, Maria Regina Catai
Pinto, Luciana D.
author_sort Isaac, Cassiano Rodrigues
title Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_short Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_full Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_fullStr Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_full_unstemmed Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
title_sort botox® after botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports
publisher Conselho Brasileiro de Oftalmologia
publishDate 2017
url http://repositorio.unb.br/handle/10482/28266
_version_ 1641988333631438848
score 13.657419